Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199

Published in Molecular Cancer Therapeutics, October 28, 2021  Authors: Beatrice T. Wang, Tasnim Kothambawala, Ling Wang, Thomas J. Matthew, Susan E. Calhoun, Avneesh K. Saini, ...

In the Media: An IgM antibody platform to tackle SARS-CoV-2 and its variants

Published in Drug Target Review.

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Published in Nature, 03 June 2021 Citation: Ku, Z., Xie, X., Hinton, P.R. et al. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 ...

In the Media: Nature Biotechnology – Bispecific Antibodies Poised to Deliver Wave of Cancer Therapies

Citation: Sheridan, C. Bispecific antibodies poised to deliver wave of cancer therapies. Nat Biotechnol 39, 251–254 (2021)

Structure, Function, and Therapeutic Use of IgM Antibodies

Published in Antibodies – Special Issue Structure and Function of Antibodies